These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7592522)

  • 1. Leukoreduced platelet apheresis production with a modified COBE spectra collection protocol.
    Kuriyan M; Opalka A
    J Clin Apher; 1995; 10(2):85-6. PubMed ID: 7592522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
    Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
    Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates.
    Zingsem J; Glaser A; Weisbach V; Zimmermann R; Neidhardt B; van Waeg G; Eckstein R
    Vox Sang; 1998; 74(3):189-92. PubMed ID: 9595647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of plateletapheresis using four apheresis systems on the same donors.
    Burgstaler EA; Pineda AA; Bryant SC
    J Clin Apher; 1999; 14(4):163-70. PubMed ID: 10611625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plateletpheresis: comparison of platelet yields, processing time, and white cell content with two apheresis systems.
    Burgstaler EA; Pineda AA; Brecher MA
    Transfusion; 1993 May; 33(5):393-8. PubMed ID: 8488542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
    Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
    J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of quality assurance in plateletpheresis.
    Moog R; Müller N
    Transfus Sci; 1999 Oct; 21(2):141-5. PubMed ID: 10747522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WBC subset analysis of WBC-reduced platelet components.
    Triulzi DJ; Meyer EM; Donnenberg AD
    Transfusion; 2000 Jul; 40(7):771-80. PubMed ID: 10924603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of plateletpheresis using Cobe Spectra System and Fresenius AS 104.
    Kautz H; Wienhausen V; Müller N
    Infusionsther Transfusionsmed; 1992 Apr; 19(2):59-60. PubMed ID: 1623319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plateletapheresis: comparison of processing times, platelet yields, and white blood cell content with several commonly used systems.
    Burgstaler EA; Pineda AA; Wollan P
    J Clin Apher; 1997; 12(4):170-8. PubMed ID: 9483178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved removal of white cells with minimal platelet loss by filtration of apheresis platelets during collection.
    Holme S; Andres M; Goermar N; Giordano GF
    Transfusion; 1999 Jan; 39(1):74-82. PubMed ID: 9920170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of FFP as a by-product of plateletpheresis.
    Zingsem J; Weisbach V; Zimmermann R; Glaser A; Bunkens H; Eckstein R
    Transfusion; 2002 Jan; 42(1):81-6. PubMed ID: 11896317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; van Waeg G; Eckstein R
    Transfusion; 1997 Oct; 37(10):1045-9. PubMed ID: 9354823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plateletpheresis efficiency: a comparison of the spectra LRS and AMICUS separators.
    Benjamin RJ; Rojas P; Christmas S; Neal J; Broughton S; Burgio C; Barrett B; Churchill WH
    Transfusion; 1999 Aug; 39(8):895-9. PubMed ID: 10504127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components.
    Adams MR; Dumont LJ; McCall M; Heaton WA
    Transfusion; 1998 Oct; 38(10):966-74. PubMed ID: 9767748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Amicus Separator in the collection of apheresis platelets.
    Yockey C; Murphy S; Eggers L; Garratty G; Dingle A; Helms C; Moroff G
    Transfusion; 1998 Sep; 38(9):848-54. PubMed ID: 9738625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.